SCHEMBL5147308

SCHEMBL5147308

O=CC(Br)c1ccc(I)s1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
WRN Q14191 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1811728 0.78
SCHEMBL193502 0.77 CES2 (0.35) WRN
SCHEMBL21495021 0.77 CES2 (0.35) WRN
SCHEMBL1849742 0.75 GABBR2 (0.39) WRN
SCHEMBL21495048 0.75 ALOX5 (0.40)
SCHEMBL6865647 0.75 ALOX5 (0.40)
SCHEMBL5319115 0.75 DAO (0.33)
SCHEMBL28808975 0.71
SCHEMBL6128179 0.69 GRM8 (0.37)
SCHEMBL14058869 0.69 ALOX5 (0.44) WRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3057963-A1 PIPERAZINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT Boehringer Ingelheim International GmbH (DE) 2016-08-24 EP disclosed
WO-2015055698-A1 PIPERAZINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-04-23 WO disclosed
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed